Those who can take Victoza are people diagnosed with type 2 diabetes mellitus. While this medicine was conceived as an antidiabetic, some endocrinologists have prescribed Victoza to obese and non-diabetic patients, but Anvisa recommends caution in this attitude as there are not enough studies to show that the drug does not harm the health of […]
Victoza is an injectable medicine that contains liraglutide in its composition, is indicated for the treatment of type 2 diabetes mellitus and can be used in combination with other diabetes medications. When Victoza enters the bloodstream, in addition to controlling blood sugar, it also promotes satiety over a 24-hour period, allowing the individual to reduce
The substance liraglutide, present in the drug Victoza, has been approved by ANVISA for marketing in Brazil since 2010, with the aim of being used specifically in the treatment of type 2 diabetes, and its use is not yet indicated for weight loss. Liraglutide is a substance that stimulates insulin secretion by beta cells in
